A Prospective, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Efficacy and Safety of Atrasentan, Including Thoracic Bioimpedance, in Type 2 Diabetic Subjects With Nephropathy
Public ClinicalTrials.gov record NCT01399580. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2b, Prospective, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Efficacy and Safety of Atrasentan, Including Thoracic Bioimpedance, in Type 2 Diabetic Subjects With Nephropathy
Study identification
- NCT ID
- NCT01399580
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- AbbVie (prior sponsor, Abbott)
- Industry
- Enrollment
- 48 participants
Conditions and interventions
Conditions
Interventions
- Atrasentan Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2011
- Primary completion
- Aug 31, 2012
- Completion
- Aug 31, 2012
- Last update posted
- Oct 24, 2013
2011 – 2012
United States locations
- U.S. sites
- 28
- U.S. states
- 15
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site Reference ID/Investigator# 58144 | Phoenix | Arizona | 85032 | — |
| Site Reference ID/Investigator# 71034 | Tempe | Arizona | 85284 | — |
| Site Reference ID/Investigator# 56927 | Azusa | California | 91702 | — |
| Site Reference ID/Investigator# 70793 | Azusa | California | 91702 | — |
| Site Reference ID/Investigator# 64027 | Chula Vista | California | 91910 | — |
| Site Reference ID/Investigator# 54120 | Concord | California | 94520 | — |
| Site Reference ID/Investigator# 64026 | La Mesa | California | 91942 | — |
| Site Reference ID/Investigator# 70173 | Los Angeles | California | 90048 | — |
| Site Reference ID/Investigator# 54121 | Denver | Colorado | 80209 | — |
| Site Reference ID/Investigator# 56924 | Boynton Beach | Florida | 33472 | — |
| Site Reference ID/Investigator# 56642 | Hollywood | Florida | 33021 | — |
| Site Reference ID/Investigator# 68986 | Augusta | Georgia | 30901 | — |
| Site Reference ID/Investigator# 56644 | Chicago | Illinois | 60611 | — |
| Site Reference ID/Investigator# 54129 | Baton Rouge | Louisiana | 70808 | — |
| Site Reference ID/Investigator# 68982 | Pontiac | Michigan | 48341 | — |
| Site Reference ID/Investigator# 64023 | Albany | New York | 12206 | — |
| Site Reference ID/Investigator# 55543 | Flushing | New York | 11355 | — |
| Site Reference ID/Investigator# 54164 | Fargo | North Dakota | 58103 | — |
| Site Reference ID/Investigator# 58147 | Willoughby Hills | Ohio | 44094 | — |
| Site Reference ID/Investigator# 54123 | Bethlehem | Pennsylvania | 18017 | — |
| Site Reference ID/Investigator# 61742 | Pittsburgh | Pennsylvania | 15224 | — |
| Site Reference ID/Investigator# 54132 | Chattanooga | Tennessee | 37408 | — |
| Site Reference ID/Investigator# 54108 | Dallas | Texas | 75231 | — |
| Site Reference ID/Investigator# 54126 | Greenville | Texas | 75402 | — |
| Site Reference ID/Investigator# 58153 | Houston | Texas | 77024 | — |
| Site Reference ID/Investigator# 54110 | Houston | Texas | 77099 | — |
| Site Reference ID/Investigator# 54116 | North Richland Hills | Texas | 76180 | — |
| Site Reference ID/Investigator# 54173 | Silverdale | Washington | 98383 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01399580, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 24, 2013 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01399580 live on ClinicalTrials.gov.